OCTREOSCAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Octreoscan, and what generic alternatives are available?
Octreoscan is a drug marketed by Curium and is included in one NDA.
The generic ingredient in OCTREOSCAN is indium in-111 pentetreotide kit. There are twenty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indium in-111 pentetreotide kit profile page.
Summary for OCTREOSCAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 20 |
Patent Applications: | 79 |
What excipients (inactive ingredients) are in OCTREOSCAN? | OCTREOSCAN excipients list |
DailyMed Link: | OCTREOSCAN at DailyMed |
Recent Clinical Trials for OCTREOSCAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alexander McEwan | Phase 1/Phase 2 |
AHS Cancer Control Alberta | Phase 1/Phase 2 |
AC Camargo Cancer Center | Phase 2 |
US Patents and Regulatory Information for OCTREOSCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Curium | OCTREOSCAN | indium in-111 pentetreotide kit | INJECTABLE;INJECTION | 020314-001 | Jun 2, 1994 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OCTREOSCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Curium | OCTREOSCAN | indium in-111 pentetreotide kit | INJECTABLE;INJECTION | 020314-001 | Jun 2, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Curium | OCTREOSCAN | indium in-111 pentetreotide kit | INJECTABLE;INJECTION | 020314-001 | Jun 2, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Curium | OCTREOSCAN | indium in-111 pentetreotide kit | INJECTABLE;INJECTION | 020314-001 | Jun 2, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Curium | OCTREOSCAN | indium in-111 pentetreotide kit | INJECTABLE;INJECTION | 020314-001 | Jun 2, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OCTREOSCAN
See the table below for patents covering OCTREOSCAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Greece | 3035067 | ⤷ Try a Trial | |
Ireland | 893866 | ⤷ Try a Trial | |
Germany | 4104308 | ⤷ Try a Trial | |
Japan | 2726320 | ⤷ Try a Trial | |
Denmark | 175338 | ⤷ Try a Trial | |
Ireland | 62091 | Detectable somatostatin derivatives containing a chelating group | ⤷ Try a Trial |
Japan | H02184698 | PEPTIDE DERIVATIVE | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |